John Doyle, DrPH

President, Consulting

Fortrea

Talk to John about these topics and more:

  • Tactics for driving health innovation
  • Optimizing market access strategies for new therapies
  • Demonstrating value through HEOR
  • Drug development life cycle strategies

Artificial Intelligence (AI)

Automation

Clinical Data

Communication Strategies

Corrective and preventive action (CAPA)

Decentralized Clinical Trials (DCTs)

Digital Health

Diversity

eCOA

FDA

Licensing Strategies

Machine Learning

Medical Writing

Patient Recruitment

Pharmacology 

Phase I/Early Phase Research 

Real-World Data

Regulatory

Research and Development

Risk Mitigation

Safety

Strategic Planning

View Expert

Cassandra Erato, MSN

Chief Executive Officer

Spaulding Clinical, LLC

Talk to Cassie about these topics and more:

  • Navigating U.S. regulatory requirements, IND Submission, and Phase 1 startup and conduct 
  • Efficiencies and guidance in running Phase 1 of clinical development  
  • Understanding cardiac safety requirements and the best cost-saving methods 
  • Developing new service programs as needs emerge 
  • Rapid operational scaling/growth, strategic planning, and recapitalization 

Biostatistics

Cardiovascular

CEO

Clinical Data

Clinical Trials

Contract Research Organization (CRO)

Medical Writing

Paperless

Pharmacology 

Phase I/Early Phase Research 

Preclinical

Regulatory

Strategic Planning

View Expert